Adam Goulburn is a PhD neuroscientist turned venture investor at Dimension who founded or incubated multiple techbio companies including Cajal Neuroscience and Kallyope, often taking operational roles before recruiting dedicated entrepreneurs. He focuses on the digitization of biology and healthcare, backing technically ambitious ideas in areas like microbiome, brain-computer interfaces, and patient-accelerated drug development where patients own rich longitudinal data that can be reused across multiple trials. Adam Goulburn is a PhD neuroscientist turned venture investor at Dimension who founded or incubated multiple techbio companies including Cajal Neuroscience and Kallyope, often taking operational roles before recruiting dedicated entrepreneurs. He focuses on the digitization of biology and healthcare, backing technically ambitious ideas in areas like microbiome, brain-computer interfaces, and patient-accelerated drug development where patients own rich longitudinal data that can be reused across multiple trials.